ALLMedicine™ Systemic Lupus Erythematosus Center
Research & Reviews 25,937 results
https://www.ncbi.nlm.nih.gov/pubmed/33635234
Clinical and Experimental Rheumatology; Tang J, Lin J et. al.
Feb 26th, 2021 - Early and correct diagnosis would be beneficial for outcomes of rheumatoid arthritis (RA), but there are some limitations in current diagnostic tools. In this study, we aimed to evaluate the diagnostic value of circulating miR-22-3p and let-7a-5p ...
https://www.ncbi.nlm.nih.gov/pubmed/33635226
Clinical and Experimental Rheumatology; Yang X, Shi L et. al.
Feb 26th, 2021 - Systemic lupus erythematosus (SLE) is a typical autoimmune disease, which is associated with many factors, such as miRNAs. The effect of miRNAs encoded by X chromosome (X-linked miRNAs) plays a crucial role in autoimmune disease. This study aims t...
https://www.ncbi.nlm.nih.gov/pubmed/33635227
Clinical and Experimental Rheumatology; Long Y, Hu C et. al.
Feb 26th, 2021 - Systemic lupus erythematosus (SLE) is a complex and challenging disorder. At present, abnormal T cells are considered to be the key point in the pathogenesis of SLE, including the losing central immune tolerance of self-reactive T cells in the thy...
https://doi.org/10.1177/0885066621996257
Journal of Intensive Care Medicine; Krasselt M, Baerwald C et. al.
Feb 26th, 2021 - Patients with connective tissue diseases (CTD) such as systemic lupus erythematosus (SLE) have an increased risk for infections. This study investigated the outcome and characteristics of CTD patients under intensive care unit (ICU) treatment for ...
https://doi.org/10.1186/s12967-021-02760-2 10.1056/NEJMra1100359 10.1002/art.39818 10.1002/art.39441 10.1016/j.clim.2017.07.004 10.1146/annurev-immunol-031210-101400 10.1084/jem.192.11.1545 10.1016/j.immuni.2009.07.002 10.1038/nri3447 10.1126/science.1175870 10.1074/jbc.M111.324046 10.1016/j.cytogfr.2016.05.001 10.1016/j.it.2015.11.001 10.1016/j.celrep.2015.08.049 10.1016/j.ejca.2005.08.016 10.4049/jimmunol.1502043 10.1016/j.clim.2015.04.004 10.1016/j.phymed.2019.152965 10.1016/j.cellsig.2017.04.001 10.1093/jnci/djr190 10.1158/1535-7163.MCT-12-0002 10.1002/jcp.29413 10.1016/j.kint.2017.01.018 10.1021/ml100146z 10.1186/s13075-017-1402-1 10.1172/JCI87037 10.1038/icb.2013.62 10.1073/pnas.1801196115 10.1038/cmi.2010.18 10.1038/nrrheum.2012.58 10.1084/jem.20171976 10.1038/sj.gene.6364286 10.1371/journal.pone.0062855 10.1038/s41419-019-1315-9 10.1073/pnas.0631696100 10.1002/art.38298 10.1182/blood-2009-08-238543 10.1002/eji.201545760 10.1016/j.cyto.2009.07.003 10.1016/j.immuni.2014.02.005 10.1073/pnas.1714717115 10.1038/ki.2015.296 10.1146/annurev.immunol.26.021607.090241 10.1016/S1074-7613(00)00020-0 10.1084/jem.20051611 10.1038/ng.468 10.1038/ni.1704 10.1038/ni.3229 10.1038/mi.2015.131 10.1038/cmi.2014.58 10.1016/j.canlet.2014.04.003 10.3389/fimmu.2018.01605
Journal of Translational Medicine; Jang SG, Lee J et. al.
Feb 26th, 2021 - Autoantibody production against endogenous cellular components is pathogenic feature of systemic lupus erythematosus (SLE). Follicular helper T (TFH) cells aid in B cell differentiation into autoantibody-producing plasma cells (PCs). The IL-6 and ...
Guidelines 87 results
https://www.the-rheumatologist.org/article/acr-convergence-2020-study-data-for-lupus-rheumatoid-arthritis/
The Rheumatologist; Hickman RJ.
Nov 8th, 2020 - At the annual meeting’s second Plenary Session, Saturday, Nov. 7, speakers highlighted phase 2 results of a potential new biologic for systemic lupus erythematosus (SLE), as well as data on remission maintenance in rheumatoid arthritis (RA) after ...
https://pubmed.ncbi.nlm.nih.gov/33154498/
Scientific Reports; Cohen IV, Makunts T et. al.
Nov 4th, 2020 - Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization's List of Essential Medications for treating non-resistant malaria, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In addition, both drugs are cu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557711/
Cureus Shah L
Oct 11th, 2020 - Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the female population. Rheumatoid arthritis mainly consists of distal symmetrical deforming polyarthritis. SLE patients have immune compl...
https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-019-0495-x
Diabetology & Metabolic Syndrome; Contreras-Haro B,et al
Nov 26th, 2019 - Insulin resistance (IR) is frequently observed in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). In clinical practice, IR assessment is limited to a low proportion of patients due to cost and equipment and technical...
http://www.jrheum.org/content/early/2019/09/11/jrheum.190250
J Rheumatology; Ruacho G,et al
Sep 20th, 2019 - Secondary Sjögren’s syndrome (SLE-sSS) is an often-neglected subset of patients with Systemic lupus erythematosus (SLE). Furthermore, primary Sjögren’s syndrome overlaps and can be difficult to delineate from SLE. To shed light on the SLE-sSS subs...
Drugs 27 results see all →
Clinicaltrials.gov 26,899 results
https://www.ncbi.nlm.nih.gov/pubmed/33635234
Clinical and Experimental Rheumatology; Tang J, Lin J et. al.
Feb 26th, 2021 - Early and correct diagnosis would be beneficial for outcomes of rheumatoid arthritis (RA), but there are some limitations in current diagnostic tools. In this study, we aimed to evaluate the diagnostic value of circulating miR-22-3p and let-7a-5p ...
https://www.ncbi.nlm.nih.gov/pubmed/33635226
Clinical and Experimental Rheumatology; Yang X, Shi L et. al.
Feb 26th, 2021 - Systemic lupus erythematosus (SLE) is a typical autoimmune disease, which is associated with many factors, such as miRNAs. The effect of miRNAs encoded by X chromosome (X-linked miRNAs) plays a crucial role in autoimmune disease. This study aims t...
https://www.ncbi.nlm.nih.gov/pubmed/33635227
Clinical and Experimental Rheumatology; Long Y, Hu C et. al.
Feb 26th, 2021 - Systemic lupus erythematosus (SLE) is a complex and challenging disorder. At present, abnormal T cells are considered to be the key point in the pathogenesis of SLE, including the losing central immune tolerance of self-reactive T cells in the thy...
https://doi.org/10.1177/0885066621996257
Journal of Intensive Care Medicine; Krasselt M, Baerwald C et. al.
Feb 26th, 2021 - Patients with connective tissue diseases (CTD) such as systemic lupus erythematosus (SLE) have an increased risk for infections. This study investigated the outcome and characteristics of CTD patients under intensive care unit (ICU) treatment for ...
https://doi.org/10.1186/s12967-021-02760-2 10.1056/NEJMra1100359 10.1002/art.39818 10.1002/art.39441 10.1016/j.clim.2017.07.004 10.1146/annurev-immunol-031210-101400 10.1084/jem.192.11.1545 10.1016/j.immuni.2009.07.002 10.1038/nri3447 10.1126/science.1175870 10.1074/jbc.M111.324046 10.1016/j.cytogfr.2016.05.001 10.1016/j.it.2015.11.001 10.1016/j.celrep.2015.08.049 10.1016/j.ejca.2005.08.016 10.4049/jimmunol.1502043 10.1016/j.clim.2015.04.004 10.1016/j.phymed.2019.152965 10.1016/j.cellsig.2017.04.001 10.1093/jnci/djr190 10.1158/1535-7163.MCT-12-0002 10.1002/jcp.29413 10.1016/j.kint.2017.01.018 10.1021/ml100146z 10.1186/s13075-017-1402-1 10.1172/JCI87037 10.1038/icb.2013.62 10.1073/pnas.1801196115 10.1038/cmi.2010.18 10.1038/nrrheum.2012.58 10.1084/jem.20171976 10.1038/sj.gene.6364286 10.1371/journal.pone.0062855 10.1038/s41419-019-1315-9 10.1073/pnas.0631696100 10.1002/art.38298 10.1182/blood-2009-08-238543 10.1002/eji.201545760 10.1016/j.cyto.2009.07.003 10.1016/j.immuni.2014.02.005 10.1073/pnas.1714717115 10.1038/ki.2015.296 10.1146/annurev.immunol.26.021607.090241 10.1016/S1074-7613(00)00020-0 10.1084/jem.20051611 10.1038/ng.468 10.1038/ni.1704 10.1038/ni.3229 10.1038/mi.2015.131 10.1038/cmi.2014.58 10.1016/j.canlet.2014.04.003 10.3389/fimmu.2018.01605
Journal of Translational Medicine; Jang SG, Lee J et. al.
Feb 26th, 2021 - Autoantibody production against endogenous cellular components is pathogenic feature of systemic lupus erythematosus (SLE). Follicular helper T (TFH) cells aid in B cell differentiation into autoantibody-producing plasma cells (PCs). The IL-6 and ...
News 1,673 results
https://www.medscape.com/viewarticle/945116
Feb 1st, 2021 - The prevalence of systemic lupus erythematosus (SLE) appears to be much lower than previously believed and may pose "a potential risk to research funding for the disease," according to results of a meta-analysis involving a network of population-b...
https://www.medscape.com/viewarticle/943726
Jan 6th, 2021 - Maintaining an average hydroxychloroquine whole blood level above 1,068 ng/mL significantly reduced the risk of thrombosis in adults with systemic lupus erythematosus, based on data from 739 patients. Hydroxychloroquine (HCQ) is a common treatment...
https://www.medscape.com/viewarticle/942894
Dec 17th, 2020 - The US Food and Drug Administration (FDA) has expanded the indication for belimumab (Benlysta) to adults with active lupus nephritis who are receiving standard therapy. Roughly 40% of patients with systemic lupus erythematosus (SLE) develop lupus ...
https://www.medscape.com/viewarticle/942712
Dec 15th, 2020 - A small group of patients with systemic lupus erythematosus (SLE) who have high costs and needs and frequent hospitalizations can be identified through a shared set of sociodemographic characteristics and risk factors that distinguish them from ot...
https://www.medscape.com/viewarticle/942688
Dec 15th, 2020 - NEW YORK (Reuters Health) - Patients with systemic lupus erythematosus (SLE) are less likely to receive invasive treatment for acute myocardial infarction (AMI) and have worse AMI outcomes than do patients without autoimmune rheumatic disease (AIR...
